Chemoinformaics analysis of 1,2,3,4,5-Cyclohexanepentol
| Molecular Weight | 164.157 | nRot | 0 |
| Heavy Atom Molecular Weight | 152.061 | nRig | 6 |
| Exact Molecular Weight | 164.068 | nRing | 1 |
| Solubility: LogS | -0.08 | nHRing | 0 |
| Solubility: LogP | -2.364 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 22.0315 |
| nHD | 5 | BPOL | 12.0385 |
| QED | 0.266 |
| Synth | 3.566 |
| Natural Product Likeliness | 1.517 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.117 |
| HIA | 0.919 |
| CACO-2 | -5.224 |
| MDCK | 0.00151478 |
| BBB | 0.773 |
| PPB | 0.106827 |
| VDSS | 1.13 |
| FU | 0.741596 |
| CYP1A2-inh | 0.016 |
| CYP1A2-sub | 0.039 |
| CYP2c19-inh | 0.009 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.267 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.12 |
| CYP3a4-inh | 0.003 |
| CYP3a4-sub | 0.009 |
| CL | 1.735 |
| T12 | 0.576 |
| hERG | 0.055 |
| Ames | 0.071 |
| ROA | 0.041 |
| SkinSen | 0.06 |
| Carcinogencity | 0.013 |
| EI | 0.084 |
| Respiratory | 0.051 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.905637 |